LG 100268 (Synonyms: AGN 192620, CD3127) |
Katalog-Nr.GC44059 |
LG 100268 (LG268) ist ein potenter, selektiver und oral aktiver Retinoid-X-Rezeptor (RXR)-Agonist mit EC50-Werten von 4 nM, 3 nM und 4 nM für RXR-α, RXR-β bzw. RXR-γ.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 153559-76-3
Sample solution is provided at 25 µL, 10mM.
LG 100268 is an agonist of retinoid X receptors (RXRs; Kd = 3 nM). It is selective for RXRs over retinoic acid receptors (RARs; Kd = >10,000 nM). In vitro, LG 100268 (1 µM) induces apoptosis in HL-60 human leukemia cells when used in combination with TTNPB . LG 100268 (100, 300, and 1,000 nM) dose-dependently inhibits COX-2 expression and increases ATP-binding cassette transporter (ABCA1) levels in macrophage-like RAW 264.7 cells. In vivo, it inhibits vinyl carbamate-induced lung tumor growth in mice when administered at a dose of 40 mg/kg.
Average Rating: 5
(Based on Reviews and 9 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *